ANKRD2 p.Ser106Trp
c.317C>G · VCV4640725
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2744 | likely benign |
|---|---|---|
| REVEL | 0.165 | moderately benign-leaning |
| SaProt | LLR -9.55 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.5 | GERP 1.8, phastCons 0.47 |
| Regional constraint | o/e 0.92 | unconstrained · MANE · 11 kb · p 0.092 · regional, not allelic |
| Overall | ||
| CADD | 21.3 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S133W vs ClinVar S106W) — verify the residue.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- ANKRD2
- Protein
- p.Ser106Trp
- Coding
- c.317C>G
- MANE Select
- NM_001346793
- Type
- single nucleotide variant
- Location
- chr10:97578367 (GRCh38)
- Gene constraint
- LOEUF 1.426 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 77.30
- Residue 106
- the 'may mediate interaction with pml, p53/tp53 and ybx1' region
Similar variants
- ANKRD2 p.Ala285= Benign ★★ same type
- ANKRD2 p.Pro119Leu Benign/Likely benign ★★ ⚠ same type
- ANKRD2 p.Pro6Arg Benign ★★ same type
- ANKRD2 p.Ala10Val Uncertain significance ★ ⚠ same type
- ANKRD2 p.Ala128Val Uncertain significance ★ ⚠ same type
- ANKRD2 p.Ala12Thr Uncertain significance ★ ⚠ same type
- ANKRD2 p.Ala311Val Uncertain significance ★ ⚠ same type
- ANKRD2 p.Arg100Pro Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ankrd2-p-ser106trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown